Patents by Inventor John M. Eustermann

John M. Eustermann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR PROVIDING A PERSONALIZED CANNABINOID TREATMENT REGIMEN
    Publication number: 20260011426
    Abstract: Methods and systems for providing a personalized cannabinoid treatment regimen to a patient include obtaining genotypes of single nucleotide polymorphisms (SNPs) from a patient's genetic test and modifying base values, such as base dosages or base ratios, using weighting values reflecting the obtained genotypes to obtain regimen values for treating the patient. The regimen values take into account expected responses to cannabinoids based on patient genetic information.
    Type: Application
    Filed: September 11, 2025
    Publication date: January 8, 2026
    Inventors: Xing-liang Liu, Douglas Ry Wagner, John M. Eustermann, Gregg M. Steinberg
  • Method and system for providing a personalized cannabinoid treatment regimen
    Patent number: 12431227
    Abstract: Methods and systems for providing a personalized cannabinoid treatment regimen to a patient include obtaining genotypes of single nucleotide polymorphisms (SNPs) from a patient's genetic test and modifying base values, such as base dosages or base ratios, using weighting values reflecting the obtained genotypes to obtain regimen values for treating the patient. The regimen values take into account expected responses to cannabinoids based on patient genetic information.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: September 30, 2025
    Assignee: GREENWAY DNA INC.
    Inventors: Xing-liang Liu, Douglas Ry Wagner, John M. Eustermann, Gregg M. Steinberg